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Table. Comparison of baseline, laboratory, echocardiographic and arterial
stiffness parameters between the groups
Variables
GFRhigh Group
(n¼143)
GFRlow Group
(n¼142) P value
Age (Years) 43.19.0 56.910.1 <0.001
LVM (g) 168.044.6 183.446.1 0.004
NT-proBNP (pg/ml) 50.638.9 117.669.5 <0.001
PWV (m/s) 6.791.02 8.581.53 <0.001
AIx (%) 27.612.0 30.911.6 0.020
LVM; left ventricular mass, NT-proBNP; N terminal pro-brain natriuretic peptide, PWV; pulse
wave velocity, AIx; augmentation index
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Sgroups in terms of age, hyperlipidemia, body mass index, smoking and family history.
Left ventricular global longitudinal strain and circumferential strain levels were
signiﬁcantly impaired in group 1 compared to group 2 (14.73.3, 22.62.3; p<0.001
and 15.32.7, 20.72.8; p<0.001, respectively) whereas no signiﬁcant difference
was observed between groups in terms of radial strain levels (36.52.7, 37.43.3;
p¼0.146). Left ventricular global longitudinal and circumferential strain values were
14.23.3 vs 15.12.8, respectively in the subgroup with high normal blood pressure
and 15.33.2 and 15.62.7, respectively in the subgroup with normal blood pressure,
however there was no signiﬁcant statistical difference (p:0.162 and p:0.422,
respectively).
Conclusion: Left ventricular longitudinal and circumferential strain are impaired in
patients with prehypertension, compared to patients with optimal blood pressure.
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Background: Hypertension being a multigenetic disease, the gene-gene interactions
(epistasis) among the variants would consolidate global overview on gene-disease
interactions.
Methods: Genetic variants in angiotensin converting enzyme (ACE), Angiotensin II
receptor, type-1 (AT1R), angiotensinogen (AGT), aldosterone synthase (CYP11B2),
endothelial nitric oxide synthase (NOS3), b2-adrenergic receptor (ADRB2), fat mass
obesity associated gene (FTO) and guanine nucleotide binding protein, b-polypeptide
3 (GNB3) belonging to pathways like renin-angiotensinogen-aldosterone system
(RAAS), kallikrein-kinin system (KKS), adrenergic receptor, nervous system and G
protein coupled receptors family were screened using PCR-RFLP and SNaPshot
methods in age- and -ethnicity matched case-control 1500 north-Indian subjects. The
study was approved by Human ethics committee.
Results: Gene-gene interactions revealed few best disease predicting models (p<0.01)
such as the ACE I/D, AT1R 1166A/C and AGT –532C/T, –20A/C, –6G/A 235M/T;
CYP11B2 -344T/C, Iw/Ic and NOS3 -922A/G, -786T/C, 4b/4a, 894G/T; FTO
rs8050136C/A and GNB3 rs1129649T/C, 825C/T. The ORs (odds ratios) for
CYP11B2 and NOS3 risk interacted-haplotypes (-344T/Ic) + (-922A/-786T/4a/894G)
and (-344T/Ic) + (-922G/-786C/4a/894G) were 5.3 and 3.9, respectively (p0.04);
whereas the OR for protective interacted-haplotypes (-344T/Iw) + (-922A/-786T/4b/
894G) was 0.7 (p¼0.03). Furthermore, stratiﬁcation of interacted 4- and 5-locus
models comprising polymorphisms of ADRB2 and NOS3 on the basis of increasing
number of risk alleles demonstrated remarkable augmentation in the OR from 1.3 to
14.2 (p¼0.508-4.51E-07) for hypertension susceptibility compared to respective
individual gene models. Likewise stratiﬁcation of 3-locus best model of FTO
rs8050136C/A and GNB3 rs1129649T/C and 825C/T on the basis of interacted-
genotypes comprising 1, 2, 3, 4 and 5 risk alleles correlated linearly with increased
ORs from 1.9 to 11.6 for hypertension (p<0.01) compared to interacted-genotypes
devoid of risk alleles. Of note, the genetic outcomes were further consolidated
by signiﬁcant varied clinical, biochemical parameters and expression levels,
(p<0.05).
Debates: This study demonstrated the importance of non-linear interactions (epistasis)
among the genes of several pathways in hypertension pathophysiology. A global
cumulative consensus will immensely beneﬁt the diagnosis and therapeutics.
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Background: Even a slight decrease in the glomerular ﬁltration rate (GFR) is an
independent risk factor for cardiovascular disease. Arterial stiffness, left ventricular
hypertrophy and N-terminal pro-brain natriuretic peptide (NT-proBNP) are indepen-
dent risk factors for cardiovascular disease, which are particularly common in end-
stage renal disease. We aimed to evaluate the association between GFR with arterial
stiffness, left ventricle mass (LVM) and NT-proBNP in hypertensive subjects with
normal to mildly impaired renal function.
Methods: The study population consisted of 285 newly diagnosed hypertensive
patients (Mean age; 49.911.8 years). GFR was estimated (eGFR) by the Modiﬁ-
cation of Diet in Renal Disease formula. Pulse wave velocity (PWV) and
augmentation index (AIx) which reﬂects arterial stiffness, were calculated using the
single-point method via the Mobil-O-Graph ARCsolver algorithm. LVM was
obtained by echocardiography. Plasma NT-proBNP was measured by electro-
chemiluminescence. The patients were divided into two groups according to the
median eGFR value (eGFRlow group <101 and eGFRhigh group 101).C14 JACC VResults: LVM and NT-proBNP values were higher in eGFRlow group compared
with eGFRhigh group (p<0.05). Pulse wave velocity and augmentation index
values were higher in eGFRlow group compared with eGFRhigh group (p<0.05,
for all) (Table). Multiple linear regression analysis showed that eGFR was indepen-
dently associated with PWV (b¼-0.422, p<0.001) and NT-proBNP (b¼-0.404,
p<0.001).
Conclusions: Present study showed that eGFR was independently associated with
PWV and NT-proBNP values. Importantly, these ﬁndings may explain, in part, the
increase in cardiovascular risk in with slightly impaired renal function.OP-037
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Objective: Beta blockers and diuretics are frequently associated with erectile
dysfunction (ED). However, the deﬁnitive mechanisms of ED secondary to these
drugs are still unclear. Uric acid is a novel marker of atherosclerosis and endothelial
dysfunction. Also, endothelial dysfunction plays a major role in ED. A common
adverse effect of thiazide like diuretics is increase in serum uric acid level. We aimed
to examine association between thiazide like diuretic uric acid and erectile dysfunction
in hypertensive patients.
Method: A total of 200 current hypertensive patients (age between 30-70 years) were
enrolled in this prospective study. ED was assessed by using SHIM test. After,
demographic characteristics of patients were recorded; serum uric acid levels and the
other laboratory analysis were performed following 12 hours fasting. Ofﬁce blood
pressure (BP) was measured and a detailed data about antihypertensive treatments
were recorded. Patients divided into two groups based on the SHIM test. Patients with
SHIM score <21deﬁned as ED and SHIM score 21 deﬁned as normal erectile
function. Difference between ED and normal erectile function group was compared
and predictors of ED were analyzed. The effect of thiazide-like diuretics on ED and
uric acid level was also tested.
Results: Prevalence of ED was found 55.0%. A total of 72 patients (36%) were using
thiazide like diuretic. Ofﬁce BP level was comparable between groups. Beta blocker
users, smokers and diabetics were frequent in ED group. Age, uric acid levels
(6.201.56 vs 5.441.32, p¼0.01), GFR and fasting glucose levels were signiﬁcantly
increased in ED group. Demographic characteristics and laboratory ﬁndings of
patients with and without ED were presented in Table1.Multiple logistic regression
model showed that age (odds:1.08 (1,04-1.14), p¼0.001), smoking (odds: 2.33 (1.04-
5.20), p¼0.04), and uric acid (odds: 1.76 (1.28-2.41), p¼0.04) were independent
predictors of ED. Beta blockers and thiazide like diuretics did not reach statistically
signiﬁcance in regression model. However, uric acid levels were increased in patients
using thiazide like diuretic compared to non-using patients (6.301.5 vs 5.51.5 mg/
dl, p¼0.05, respectively). A weak negative correlation was observed between SHIM
score and uric acid level (r¼-20.4, p¼0.01). For indicating ED in ROC analysis, a cut-
off value for uric acid level of greater than 5.2 had 76.2% sensitivity, 43.7% speci-
ﬁcity, 62.9 positive predictive value, and 59.4 negative predictive value for prediction
of ED (Figure1.)
Conclusion: A large number of hypertensive patients suffer from ED regardless
BP levels. Uric acid is an independent predictor of ED and thiazide like diuretics
mediated increase in serum uric acid levels may contribute to ED via endothelial
dysfunction.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
